Loading...
NPI 1598748782 · Monroe, LA · Clinical Medical Laboratory
Customize your policy alerts
Get alerted when relevant policies change without checking for updates manually.
Monitor payer policy activity
Laboratory Corporation Of America Holdings is a clinical medical laboratory provider located in Monroe, Louisiana. This profile covers 117 Medicare and 125 Medicaid CPT/HCPCS procedure codes, with claims volume, average reimbursement, and total revenue by code, benchmarked against other providers billing the same services.
Provider details (source: NPPES NPI Registry)
| Field | Value |
|---|---|
| Entity Type | Organization |
| Organization | Laboratory Corporation Of America Holdings |
| Address | 109 Circle Dr |
| City | Monroe |
| State | LA |
| ZIP | 71203 |
| Taxonomy | Clinical Medical Laboratory |
| NPI Enumerated | November 22, 2005 |
Lifetime revenue by payer source (source: CMS Medicare & Medicaid claims data)
| Payer Source | Total Paid |
|---|---|
| Medicaid | $3.4M |
| Medicare | $1.2M |
LABORATORY CORPORATION OF AMERICA HOLDINGS in Monroe, LA (Clinical Medical Laboratory taxonomy) shows a code mix dominated by routine chemistry and hematology panels (examples include 80053, 80061, 85025, 83036) alongside substantial microbiology work (87086, 87088, 87186, 87077), which together point to a centralized clinical lab operation that handles high volumes of outpatient diagnostic testing and culture/susceptibility services. The presence of PLA and high-complexity infectious codes (e.g., 0202U, 87507) further indicates capacity for proprietary multiplex molecular testing in addition to standard analytes and cultures.
Revenue is moderately concentrated within a few Medicare codes: the precomputed top 3 Medicare codes by revenue account for 38.7% of this provider's total Medicare revenue, and the listed Medicare top codes (80053, 85025, 87086) each appear among the highest-revenue services. With Total Medicare revenue of $1.2M, these top codes represent a meaningful share of the Medicare book of business and reflect dependence on routine panels and culture services for Medicare income.
Medicaid revenue shows a larger scale and a different composition: Total Medicaid revenue of $3.4M is materially larger than Medicare, and the precomputed top 3 Medicaid codes by revenue account for 30.8% of Medicaid revenue. High-revenue Medicaid items include 0202U ($383.9K) and 87086 ($315.4K), indicating that both high-priced PLA/multiplex molecular testing and very large-volume culture work drive Medicaid receipts.
The provider’s payer mix is Medicaid-weighted: with $3.4M in Medicaid revenue versus $1.2M in Medicare, Medicaid is the dominant payer by scale in this dataset. This asymmetry suggests the lab’s commercial or contractual positioning and specimen sources are oriented toward Medicaid populations and referral patterns in-state.
National competitive standing on Medicare appears high by rank but labeled as typical volume for many codes: examples include 80053 (rank #150 of 26416, 99th percentile) and 85025 (rank #142 of 32833, 100th percentile) where the dataset notes "typical, unremarkable volume for this code." In plain terms, the lab posts strong national rankings on common panel codes but the commentary characterizes these as expected volumes for a large lab rather than exceptional specialty dominance.
State-level competitive standing on Medicaid is concentrated and dominant for microbiology: multiple culture and susceptibility codes are described as "extreme outlier" in-state — for example, 87086 ranks #2 of 126 (99th percentile, extreme outlier), 87088 ranks #2 of 48 (98th percentile, extreme outlier), 87081 ranks #1 of 89 (100th percentile, extreme outlier), 87186 ranks #2 of 53 (98th percentile, extreme outlier), and 87077 ranks #2 of 60 (98th percentile, extreme outlier). These labels indicate the provider is a major in-state hub for bacterial culture and antimicrobial susceptibility testing on the Medicaid side.
The presence and contribution of proprietary and molecular tests are notable within Medicaid: 0202U (a PLA for the BioFire FilmArray RP2.1) generated $383.9K and ranks #21 of 60 in-state (66th percentile), and multiplex NAATs such as 87507 ($186.2K) and 87633 ($144.2K) also appear in the top Medicaid revenue list. This pattern signals laboratory capability and revenue dependence on molecular respiratory and GI pathogen panels alongside traditional microbiology.
The provider has longstanding enrollment and established credentials: the NPI was enumerated on 2005-11-22 (~21 years ago), confirming long tenure in the Medicare/Medicaid programs. Combined with the Clinical Medical Laboratory taxonomy and the heavy volumes observed across both routine chemistry and microbiology codes, the data portray an established diagnostic laboratory with deep in-state microbiology footprint and substantial Medicaid-facing revenue streams.
Medicare revenue breakdown by CPT/HCPCS procedure code.
View: Bar Chart1 / 2
The CPT/HCPCS codes generating the most Medicare revenue for this provider.
117 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 16,020 | $10 | $160.2K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 16,190 | $10 | $129.5K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 12,370 | $10 | $98.9K |
| 84443 | The lab analyst performs a test to measure the amount of thyroid–stimulating hormone (TSH), a hormone produced in the pituitary gland that helps regulate thyroid function. The typical specimen is the… | 5,860 | $20 | $93.8K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 5,970 | $10 | $77.6K |
| 36415 | In this procedure, the provider inserts a needle into a vein to collect a blood sample. | 8,100 | $10 | $64.8K |
| 87186 | The lab analyst performs the technical steps to evaluate a culture isolate’s susceptibility, or sensitivity, to multiple antimicrobial agents, commonly called antibiotics, by observing growth of the… | 6,740 | $10 | $53.9K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 1,850 | $30 | $53.6K |
| 87088 | The lab analyst or microbiologist observes a urine culture with an unknown organism or organisms and makes a presumptive identification of each organism that needs identification. | 6,120 | $10 | $49K |
| 83036 | Sugar in the bloodstream can get attached to the hemoglobin in red blood cells. Once the sugar is attached, it stays there for the lifetime of the red blood cell (around 120 days or over 3 months).… | 3,820 | $10 | $38.2K |
Showing 1–10 of 117
How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 117 CPT/HCPCS codes.
View: State1 / 2
Full comparison — all codes billed, vs. state median
Medicaid revenue breakdown by year and by CPT/HCPCS procedure code, including monthly billing trends and the top codes driving revenue.
View: By Year1 / 3
Every CPT/HCPCS code this provider has billed to Medicaid, with claims volume, average payment, and total revenue.
125 rows
| CPT/HCPCS Code | Description | Claims | Avg Paid | Revenue |
|---|---|---|---|---|
| 0202U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0202U for the… | 2,300 | $170 | $383.9K |
| 87086 | Culture, bacterial; quantitative, colony count, urine. | 78,840 | $1 | $315.4K |
| 80050 | The lab analyst performs testing for the specific group of clinical laboratory procedures in the general health panel. Payers typically consider 80050 to apply only when the clinician orders the… | 11,740 | $20 | $223.1K |
| 80053 | The lab analyst performs a comprehensive metabolic panel, or CMP test in which he measures the blood level of 14 chemicals the code descriptor lists for the panel. | 55,620 | $1 | $222.5K |
| 87507 | The lab analyst performs a test to detect 12 to 25 types or subtypes of a pathogen, such as Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia, that affects the gastrointestinal… | 810 | $230 | $186.2K |
| 85025 | A complete blood count (better known as a CBC) is a blood test request by a doctor that provides detailed information about various types of cells in a patient's blood. Usually a pathologist or a… | 53,480 | $1 | $160.4K |
| 80061 | The lab analyst performs a lipid panel test in which he measures the blood level of cholesterol and fats called triglycerides in the blood. | 29,300 | $10 | $146.5K |
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 4,650 | $30 | $144.2K |
| 82306 | The lab analyst measures the vitamin D level, typically on a serum specimen. This analyte, commonly known as vitamin D, is not really a vitamin, but is an important steroid hormone that is produced… | 9,380 | $10 | $121.9K |
| 87088 | The lab analyst or microbiologist observes a urine culture with an unknown organism or organisms and makes a presumptive identification of each organism that needs identification. | 28,030 | $1 | $112.1K |
Showing 1–10 of 125
How this provider's Medicaid billing volume and revenue compare to other Louisiana providers billing the same CPT/HCPCS codes.
Full comparison — all codes billed, vs. Louisiana median
125 rows
| CPT/HCPCS Code | Description | Rank | Provider Count | Median Claims | Avg Paid | Average Revenue |
|---|---|---|---|---|---|---|
| 87633 | The lab analyst performs a test to identify a respiratory virus using amplified nucleic acid probe technique. He may also use a multiplex reverse transcription technique. The provider does this for… | 9 | 70 | 620 | $230 | $913.4K |
| 0202U | This is a Proprietary Laboratory Analyses (PLA) code, meaning that the code applies to only one unique lab test made by a specific manufacturer or performed by a specific lab. Report 0202U for the… | 21 | 60 | 1,160 | $280 | $690.6K |
| 87507 | The lab analyst performs a test to detect 12 to 25 types or subtypes of a pathogen, such as Clostridium difficile, E. coli, Salmonella, Shigella, norovirus, Giardia, that affects the gastrointestinal… | 3 | 10 | 210 | $280 | $667.5K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high… | 51 | 100 | 620 | $40 | $560K |
| 87798 | The lab analyst performs a test for an infectious agent not specified in another code using an amplified nucleic acid probe technique. Use this code if you know the laboratory technique is amplified… | 20 | 90 | 650 | $40 | $404.2K |
| 80307 | The lab analyst performs presumptive drug test(s) via instrumented chemistry analyzers to screen for any number of drug classes on a single date. | 153 | 170 | 1,360 | $30 | $190K |
| 83021 | The lab analyst measures and calculates the hemoglobin fractions in a whole blood sample demonstrated by this hemoglobin fractionation test by chromatography. | 21 | 20 | 160 | $10 | $140.7K |
| 87591 | The lab analyst performs a lab test for Neisseria gonorrhoeae, also called GC, using amplified nucleic acid probe technique. | 41 | 190 | 1,000 | $30 | $139.9K |
| 87491 | The lab analyst performs a test for Chlamydia trachomatis using amplified nucleic acid probe technique. | 41 | 190 | 900 | $30 | $137.2K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but… | 22 | 20 | 290 | $60 | $136.6K |
Showing 1–10 of 125
Other providers in the same ZIP code as Laboratory Corporation Of America Holdings, ranked by combined Medicare and Medicaid revenue.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.